Agilon health Appoints Jeff Schwaneke as New Chief Financial Officer

Agilon health, inc. (NYSE: AGL), a trusted partner empowering physicians to transform healthcare in communities, announced today that Jeff Schwaneke, an experienced finance, operational, and managed care executive, and current director on agilon’s board, will join the company as Chief Financial Officer and Executive Vice President effective July 1, 2024. Schwaneke will be part of agilon’s Executive Leadership team and will report to CEO Steve Sell. He succeeds Timothy Bensley, who announced his retirement in early 2024 and will stay on through a transition period.

Previously, Schwaneke was Executive Vice President of Health Care Enterprises at Centene Corporation, a Fortune 50 company and leading healthcare enterprise. He brings over 27 years of finance and operational expertise, including 15 years in the managed care sector. In his new role, Schwaneke will be a key thought partner to agilon’s CEO, board of directors, and Executive Leadership team, overseeing all aspects of the company’s financial operations. He will step down from agilon’s board of directors, which he joined in 2022, upon starting his new role.

“On behalf of the board of directors, I am delighted to support Jeff’s appointment as agilon’s new Chief Financial Officer,” said Ron Williams, board chairman. “Jeff’s extensive experience in managed care has provided exceptional insights to agilon regarding payors, primary care physicians, and the evolving managed care landscape. We look forward to his continued contributions.”

“Demand for agilon’s model among physician practices and payors has never been stronger, and we are excited to welcome Jeff as our Chief Financial Officer at this pivotal moment,” said Steve Sell, CEO. “Jeff’s leadership, financial, and industry experience have been invaluable to agilon and our physician partners, and we look forward to his ongoing insights and expertise in his new role.”

Steve Sell added: “I would like to thank Tim Bensley for his numerous contributions to agilon and our partnership model over the past three years. We wish him the best in his retirement.”

During his 13 years at Centene, Schwaneke held numerous positions and played a key role in raising capital, leading acquisitions, and integrating newly acquired companies. As Executive Vice President of Health Care Enterprises, Schwaneke oversaw Centene’s $35 billion pharmacy business, including Medicare Part D, dental and vision companies, and company-owned clinics. He previously served as Centene’s Chief Financial Officer and Treasurer from 2016 to 2021, during which revenues grew from $20 billion to $125 billion. Schwaneke joined Centene in 2008 as Corporate Controller and Chief Accounting Officer. Prior to joining Centene, he held finance and accounting positions at Novelis Inc., SPX Corporation, and PriceWaterhouseCoopers. Schwaneke holds a Bachelor’s degree in Accounting from the University of Missouri and is a CPA (inactive).

Jeff Schwaneke said: “As a director, I have seen firsthand the critical role agilon plays in transforming healthcare delivery. I am excited to join Steve and the Executive Leadership team to continue meeting the growing demand for agilon’s model among physicians and payors.

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter